Month: February 2007

How many people are in dire need for new HIV meds in the US in 2007

The number of salvage patients may be calculated with some current data and assumptions:450,000 under treatment in the US Assume: aconservative high estimate of 60 % of patients treated have undetectable viral load (under 50 copies per ml)(from 96 week studies of different drugs) so, 40 % have over 50 copies per ml out of …

How many people are in dire need for new HIV meds in the US in 2007 Read More »

Comments from Dr Paul Bellman about HIV rescue therapy

Dear Nelson and Friends, I read with interest the attached excellent review of treatment strategies for PRN Notebook by Dr’s Charles Farthing and Athe Tsibris. I believe and feel strongly that two incorrect conclusions might be drawn from the studies presented in article that could adversely effect treatment strategy in individual patients. 1. Firstly, the …

Comments from Dr Paul Bellman about HIV rescue therapy Read More »

The second wave of HAART: Combining MK 518 plus TMC 125 or Maraviroc

Now, patients with HIV multidrug resistance can start three active drugs in three different expanded access programs! This is the first time this has been possible in the 25 years of the AIDS epidemic. The closest thing to this wonderful time was the 1996-1998 period. This information was provided by Merck (Feb 20, 2007): Co-Administration …

The second wave of HAART: Combining MK 518 plus TMC 125 or Maraviroc Read More »

Maraviroc, a new entry inhibitor, available via expanded access

First watch this cool video that explains how Maraviroc workshttps://www.maraviroceap.com/interested_healthcare_professional/ccr5_tropism_video.aspx Overview and Registration for the Maraviroc EAP——————————————————————————– Overview of the Maraviroc EAPWelcome to the Maraviroc EAP Website. Maraviroc is an investigational drug being developed for use in combination with other antiretroviral medications for the treatment of human immunodeficiency virus, type-1 (HIV-1) infected treatment-experienced patients. Maraviroc …

Maraviroc, a new entry inhibitor, available via expanded access Read More »

Scroll to Top